EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanotechnology in dermatologic therapy: clinical advances and emerging translational perspectives over the past decade

Clarissa Prati Bernardi Cogo, Mayra Ianhez, Renata Bertino, Anderson Alves Costa, Adilson Costa, Hélio Amante Miot

Anais Brasileiros de Dermatologia · 2026-09 · 101 (5) · 501427

DOI: 10.1016/j.abd.2026.501427 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Anais Brasileiros de Dermatologia, 2026-09. Verfasst von Clarissa Prati Bernardi Cogo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil. Electronic address: cprati2018@gmail.com. Hauptthemen laut MEDLINE: Skin Diseases, Nanotechnology, Dermatologic Agents, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanotechnology has been revolutionizing science for at least five decades, with continuous expansion into various medical fields and the introduction of innovative strategies for the management of cutaneous conditions, particularly over the past decade. This article reviews the primary scientific evidence and recent technological advances regarding the application of nanoparticles in the management of skin diseases, highlighting their translational and regulatory relevance. The incorporation of nanocarriers has enabled the optimization and control of skin penetration, bioavailability, and drug and cosmetic active release, with improved safety and tolerability. These platforms have broadened therapeutic options for dermatoses and enhanced cosmetic outcomes in rejuvenation, hydration, and photoprotection. Nanoparticulate actives have demonstrated potential for improved efficacy and tolerability in selected clinical contexts, with greater patient adherence. In parallel, the use of nanotechnology in dermocosmetics and daily-use products has been growing exponentially, demanding greater regulatory standardization and strengthened oversight of manufacturing quality processes. Despite these advances, challenges remain regarding methodological reproducibility, physicochemical characterization, and traceability of nanomaterials. Furthermore, this critical narrative review acknowledges limitations, including heterogeneity in study designs and a lack of long-term data, which are necessary for a comprehensive understanding of the full impact of nanotechnology in dermatology. The integration of scientific innovation, regulation, and clinical practice is essential to consolidate the safe and effective use of nanoparticles in modern dermatology. Thus, nanotechnology represents a transition toward more precise, multifunctional, and personalized cutaneous therapies, with the potential to impact dermatologic public health and overall well-being.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin DiseasesNanotechnologyDermatologic AgentsNanoparticlesHumansTranslational Research, Biomedical

Stichwörter der Autor:innen

Drug delivery systemsNanoparticlesNanotechnologyTopical drug administration

Substanzen

Dermatologic Agents

Autor:innen und Institutionen

  • Hospital São Lucas, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil. Electronic address: cprati2018@gmail.com.
  • Department of Dermatology, Hospital de Doenças Tropicais de Goiás, Goiânia, GO, Brazil.
  • Instituto de Educação Médica (Città), Universidade Estácio de Sá, Rio de Janeiro, RJ, Brazil.
  • Department of Dermatology, Hospital Ipiranga, São Paulo, SP, Brazil.
  • Instituto de Assistência Medica ao Servidor Público Estadual, São Paulo, SP, Brazil; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America.
  • Department of Infectology, Dermatology, Imaging Diagnosis and Radiotherapy, Faculty of Medicine, Universidade Estadual Paulista, Botucatu, SP, Brazil.

Zitieren

APA

Cogo, C. P. B., Ianhez, M., Bertino, R., Costa, A. A., Costa, A., & Miot, H. A. (2026). Nanotechnology in dermatologic therapy: clinical advances and emerging translational perspectives over the past decade. Anais Brasileiros de Dermatologia, 101(5), 501427. https://doi.org/10.1016/j.abd.2026.501427

Vancouver

Cogo CPB, Ianhez M, Bertino R, Costa AA, Costa A, Miot HA. Nanotechnology in dermatologic therapy: clinical advances and emerging translational perspectives over the past decade. Anais Brasileiros de Dermatologia. 2026;101(5):501427. doi:10.1016/j.abd.2026.501427

BibTeX
@article{Cogo2026,
  author = {Cogo, Clarissa Prati Bernardi and Ianhez, Mayra and Bertino, Renata and Costa, Anderson Alves and Costa, Adilson and Miot, Hélio Amante},
  title = {Nanotechnology in dermatologic therapy: clinical advances and emerging translational perspectives over the past decade},
  journal = {Anais Brasileiros de Dermatologia},
  year = {2026},
  volume = {101},
  number = {5},
  pages = {501427},
  doi = {10.1016/j.abd.2026.501427}
}
Kostenlos starten →